Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Hans Hull Insider Profile
4 Followers
Hans Hull, Chief Executive Officer at Adverum Biotechnologies, holds 149.04K shares in Pliant Therapeutics (Ticker: PLRX), holds 137.21K shares in Adverum Biotechnologies (Ticker: ADVM).
Hans Hull has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Hans Hull holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Jun 16, 2015 - Jun 16, 2016
Return:-79.40%
The most profitable trade made by Hans Hull
Hans Hull's Trading History
Adverum Biotechnologies
Aug 25, 2015
Chief Executive Officer
Uninformative Buy
―
$1.93M
Pliant Therapeutics
Jun 09, 2020
Chief Business Officer
Uninformative Buy
―
$4.92M
List of latest transactions for each holding click on a transaction to see Hans Hull's performance on stock
You May Also Like
Hans Hull insider profile FAQ
What is the percentage of profitable transactions made by Hans Hull?
The percentage of profitable transactions made by Hans Hull is ―.
What is the average return per transaction made by Hans Hull?
The average return per transaction made by Hans Hull is ―.
What stocks does Hans Hull hold?
Hans Hull holds: ADVM, PLRX stocks.
What was Hans Hull’s latest transaction?
Hans Hull latest transaction was an Uninformative Buy of ―.
What was Hans Hull's most profitable transaction?
Hans Hull’s most profitable transaction was an Informative Buy of ADVM stock on June 16, 2015. The return on the trade was -79.40%.
What is Hans Hull's role in Adverum Biotechnologies?
Hans Hull's role in Adverum Biotechnologies is Chief Executive Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.